Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Digging Deeper Into Cancer

Published: Tuesday, November 19, 2013
Last Updated: Tuesday, November 19, 2013
Bookmark and Share
What a pathologist looks for in a Pap test sample, but hopes not to find, are oddly shaped cells with abnormally large nuclei. The same is true for prostate and lung cancer biopsies.

“If you just open a text on the pathology of cells, you see hundreds of strange-looking cells – this one with a gigantic nucleus, that one with vacuoles that push the nucleus aside,” says Wallace Marshall, PhD ’97, an associate professor of biochemistry and biophysics. “It’s like an atlas of freakish cells.”

Marshall wondered if this lineup of distorted cells might hold a clue to a new way to fight cancer. Because cancer cells divide so quickly, they’re on a fast track to mutate and develop resistance to chemo drugs. So new drugs are continually added to the mix, often triggering an arms race between the chemo drugs and the cancer – a race that the cancer sometimes wins.

Marshall thought of a different strategy: what if the enlarged nuclei, and specialized cellular structures called organelles, actually drive cancer metabolism? If so, then developing ways to reverse organelle growth could rob cancer cells of the proteins and other resources they need to grow and proliferate.

The hypothesis exemplifies one of UC San Francisco’s precision medicine pillars: basic discovery. The long path to developing potent new treatments often starts with an observation in the lab that then leads to a question about a fundamental life process. This in turn prompts a “testable” hypothesis. Science is full of hypotheses that don’t pan out because experiments fail to support them. But those that survive the rigors of investigation can change minds – and save lives.

Marshall’s lab has begun to study the processes by which organelles enlarge. Once armed with that understanding, his team plans to test drug candidates to “deprogram” them and counter their growth.

Such a treatment approach could circumvent the key vulnerability of chemotherapy, Marshall says. It would not aim directly at the biochemical pathway that allows cancer cells to multiply rapidly – the very capacity that also allows them to mutate and develop resistance to drugs.

Instead, it would attack the cascade of chemical signals that regulates organelle growth. Marshall reasons that these signals are not likely to be the same ones that cancer cells use to mutate and evade the drugs.

Even if cancer cells did develop resistance to drugs targeting their organelle growth, Marshall says, they would have double the work to evade both these drugs and the more conventional ones countering cellular proliferation.

Marshall likens organelles to “reaction vessels” – akin to tanks in a chemical plant, churning out products through chemical reactions. The size and design of the reaction vessels, he says, are just as important as the chemistry going on inside them. Shrink the vessels, and you cut their productivity.

He actually has two hypotheses about the link between organelle size and cancer. One postulates that gargantuan nuclei and organelles derive from the cancer cell’s need to ramp up its metabolism. If the “reaction vessels” could be made to return to their earlier, smaller configuration, the cancer cell might starve.

In his second scenario, the cancer cell’s hypermetabolism is a result of organelle growth, not its cause. But, again, by driving the organelles back to a more normal size range, the cell would revert to a less malignant state.

Marshall stresses that neither scenario has been tested. That’s his long-range goal. To get there, he must first understand the natural mechanisms that regulate organelle growth. His lab is now at the stage of finding out what specific steps control organelle growth – how a cell knows the size of its nuclei and mitochondria, for example, or knows if it’s well fed.

If he can identify the genetic controls or enzymes and other molecules that underlie these processes, he would have targets for potential drugs to reprogram the abnormal growth.

In collaboration with UCSF’s Small Molecule Discovery Center, his lab is carrying out automated, “high-throughput” tests, like those used in commercial drug development, to screen for drug candidates that impede specific genes or molecules. Such screening efforts often search through tens of thousands to hundreds of thousands of compounds to find the few able to block the target enzyme.

His colleague Davide Ruggero, PhD, who holds UCSF’s Helen Diller Family Endowed Chair of Basic Science in Urological Cancer, has developed a technique to inject/introduce oncogenes into progenitors of connective tissue known as fibroblast cells. This induces tumor formation. By then using special stains to reveal the organelles in the resulting tumor cells, Marshall’s team can scrutinize cells at various stages of cancer growth.

“We have the trajectory of how they change as they become cancer cells. If we can move them back along the same trajectory, we’ll see if that can arrest the cancer growth.”

It’s a long way from a fundamental insight to an approved therapy, and Marshall is the first to admit it. But he says UCSF’s precision medicine mindset will likely play a key role in making that journey more quickly.

“I think the standard drug therapy approach is often a ‘fire and forget’ strategy – like a ballistic missile. You pick the drug, you give it to the patient, and cross your fingers that it will work. But precision medicine entails following up with more research to measure how the individual patient is responding – through physiological indicators or gene expression patterns or, if our organelle-based approaches pan out, measuring at the level of cellular structure.”

Precision medicine, then, extends the process into an ongoing, evidence-based approach to find not only whether a patient got better, but how and why and at what rate.

“This will allow us to steer patients back to a more healthy state instead of only hammering them with drugs,” Marshall says.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Tuesday, July 28, 2015
Engineers Crack DNA Code of Autoimmune Disorders
Researchers have identified an unexpectedly general set of rules that determine which molecules can cause the immune system to become vulnerable to the autoimmune disorders lupus and psoriasis.
Wednesday, June 10, 2015
Genetic Markers for Detecting and Treating Ovarian Cancer
Custom bioinformatics algorithm identifies human mRNAs that distinguish ovarian cancer cells from normal cells and provide new therapeutic targets
Wednesday, May 27, 2015
Industry-Sponsored Academic Inventions Spur Increased Innovation
Analysis questions assumption that corporate support skews science toward inventions that are less useful than those funded by the government or non-profit organizations.
Monday, March 24, 2014
Researchers Change Cell Types by Flipping a Single Switch
New findings have identified a method for changing one cell type into another in a process called forced transdifferentiation.
Friday, December 06, 2013
Scientists Pinpoint Cell Type and Brain Region Affected by Gene Mutations in Autism
UCSF-led study zeroes in on when and where disrupted genes exert effects.
Tuesday, November 26, 2013
Nanotech Method Show Promise Against Pancreatic Cancer
Researchers at UCLA's Jonsson Comprehensive Cancer Center have developed a new technique for fighting deadly and hard-to-treat pancreatic cancer.
Monday, November 18, 2013
Researchers Un-Junking Junk DNA
A study shines a new light on molecular tools our cells use to govern regulated gene expression.
Wednesday, November 13, 2013
Fast-Mutating DNA Sequences Shape Early Development
What does it mean to be human? According to scientists the key lies, ultimately, in the billions of lines of genetic code that comprise the human genome.
Wednesday, November 13, 2013
Did Inefficient Cellular Machinery Evolve to Fight Viruses and Jumping Genes?
UCSF scientist poses new theory on origins of eukaryotic gene expression.
Monday, November 11, 2013
Powerful Anti-Cancer Compound Safely Delivered
Researchers have discovered a way to effectively deliver staurosporine (STS).
Tuesday, October 22, 2013
New Insights into How Proteins Regulate Genes
Researchers have developed a new way to parse and understand how special proteins called "master regulators" read the genome, and consequently turn genes on and off.
Monday, October 21, 2013
Cell Growth Discovery Has Implications for Targeting Cancer
The way cells divide to form new cells is controlled in previously unsuspected ways.
Monday, October 21, 2013
Single Gene Mutation Linked to Neurological Disorders
Mutation could offer insights into Alzheimer’s, Parkinson’s and Huntigton’s Diseases.
Wednesday, October 16, 2013
Pan-Cancer Studies Find Common Patterns Shared by Different Tumor Types
Findings may open up new treatment options by extending therapies effective in one cancer type to others with a similar genomic profile.
Wednesday, October 02, 2013
Scientific News
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Searching Big Data Faster
Theoretical analysis could expand applications of accelerated searching in biology, other fields.
Growing Hepatitis C in the Lab
Recent discovery allows study of naturally occurring forms of hepatitis C virus (HCV) in the lab.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Reprogramming Cancer Cells
Researchers on Mayo Clinic’s Florida campus have discovered a way to potentially reprogram cancer cells back to normalcy.
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
How DNA ‘Proofreader’ Proteins Pick and Edit Their Reading Material
Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have discovered how two important proofreader proteins know where to look for errors during DNA replication and how they work together to signal the body’s repair mechanism.
Fat in the Family?
Study could lead to therapeutics that boost metabolism.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!